NCT00519207View on ClinicalTrials.gov

Evaluation of Topical Liposomal Lidocaine and Oral Sucrose for Treatment of Pain in Newborns Undergoing Venipuncture

PHASE3CompletedINTERVENTIONAL
Enrollment

330

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

February 28, 2009

Study Completion Date

February 28, 2009

Conditions
Pain
Interventions
DRUG

Lidocaine

1g of liposomal lidocaine will be administered 30-40 minutes prior to venipuncture and occluded by a dressing.

DRUG

24% Sucrose Solution

2ml of 24% sucrose will be administered 2 minutes prior to venipuncture

Trial Locations (2)

M5G 1X5

Mount Sinai Hospital, Toronto

M5G 1X8

The Hospital for Sick Children, Toronto

All Listed Sponsors
collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

lead

The Hospital for Sick Children

OTHER

NCT00519207 - Evaluation of Topical Liposomal Lidocaine and Oral Sucrose for Treatment of Pain in Newborns Undergoing Venipuncture | Biotech Hunter | Biotech Hunter